Trial Profile
Immunogenicity, Safety and Tolerability of Intradermal COVID-19 Vaccination Strategy in Immunocompromised Patients: a Prospective, Randomized Trial.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2023
Price :
$35
*
At a glance
- Drugs Tozinameran (Primary) ; Tozinameran
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 24 Feb 2023 New trial record